Xenon Pharmaceuticals Inc.
NASDAQ:XENE
45 (USD) • At close November 8, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | |||||||||||||
| Nettowinst
| -182.393 | -125.373 | -78.882 | -28.837 | -41.595 | -34.497 | -30.704 | -22.997 | -15.752 | 13.018 | 12.032 | -4.301 | -11.992 |
| Afschrijvingen & Amortisatie
| 3.541 | 1.624 | 0.906 | 0.644 | 0.429 | 0.586 | 0.649 | 0.864 | 1.038 | 0.738 | 0.705 | 0.786 | 1.132 |
| Uitgestelde Inkomstenbelasting
| -0.292 | -0.044 | 0.058 | -0.285 | -0.133 | 0.646 | -1.474 | -1.3 | 6.902 | 0.072 | 0.083 | 0.996 | -0.088 |
| Aandelen Gebaseerde Vergoedingen
| 0.032 | 20.376 | 10.017 | 5.677 | 2.924 | 2.625 | 2.236 | 2.161 | 3.729 | 0.76 | 0.648 | 0.414 | 0.447 |
| Verandering in Werkkapitaal
| 5.635 | -0.676 | -2.647 | -26.089 | 33.52 | 0.03 | 0.556 | 1.768 | -13.957 | -14.256 | -16.675 | 47.418 | -3.266 |
| Vorderingen
| 0.13 | 1.757 | -0.459 | -1.032 | -0.653 | 0.175 | -0.232 | 0.121 | -0.107 | 0.209 | -0.076 | 11.23 | -11.008 |
| Voorraden
| 0 | 0 | -2.971 | -2.022 | -4.541 | -0.783 | 0.613 | 0.571 | 0 | -0.573 | 0 | 0 | 0 |
| Crediteuren
| 3.931 | 8.062 | 2.971 | 2.022 | 4.541 | 0.783 | -0.003 | 0.547 | 0.08 | 0.518 | 0 | 0 | 0 |
| Overig Werkkapitaal
| 1.574 | -10.495 | -2.188 | -25.057 | 34.173 | -0.145 | 0.178 | 0.529 | -13.85 | -14.41 | -16.599 | 36.188 | 7.742 |
| Overige Niet-Contante Posten
| -4.19 | 5.663 | 1.046 | 0.766 | 0.223 | -4.114 | 0.011 | -0.063 | -0.063 | -0.066 | -0.115 | 0.26 | 0.078 |
| Kasstroom uit Operationele Activiteiten
| -145.327 | -98.43 | -69.502 | -48.124 | -4.632 | -34.724 | -28.726 | -19.567 | -18.103 | 0.266 | -3.322 | 45.573 | -13.689 |
| Investeringsactiviteiten: | |||||||||||||
| Investeringen in Materiële Vaste Activa
| -5.617 | -2.894 | -2.05 | -2.637 | -1.24 | -0.507 | -0.315 | -0.279 | -0.551 | -1.529 | -0.156 | -0.526 | -0.29 |
| Netto Overnames
| -682.354 | 296.003 | -144.754 | -214.71 | -75.443 | -48.522 | -52.616 | 0 | 0 | -13.539 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| -793.907 | -551.137 | -389.474 | -228.897 | -140.494 | -77.002 | -28.007 | -47.563 | 0 | -15.254 | -17.876 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 682.354 | 258.028 | 144.754 | 214.71 | 75.443 | 48.522 | 52.616 | 0 | 10.745 | 13.539 | 6.55 | 1.01 | 14.179 |
| Overige Investeringsactiviteiten
| 682.354 | -296.003 | 144.754 | 214.71 | 75.443 | 48.522 | 52.616 | -47.563 | 10.745 | 13.539 | 0.01 | 0.007 | 0 |
| Kasstroom uit Investeringsactiviteiten
| -117.17 | -296.003 | -246.77 | -16.824 | -66.291 | -28.987 | 24.294 | -47.842 | 10.194 | -3.244 | -11.472 | 0.491 | 13.889 |
| Financieringsactiviteiten: | |||||||||||||
| Schuldaflossingen
| 0 | 0 | 0 | -16.743 | 0 | -8.453 | -6.893 | 0 | 0 | 0 | -1.701 | 0 | 0 |
| Uitgifte van Gewone Aandelen
| 353.522 | 278.471 | 447.283 | 102.456 | 27.396 | 102.85 | 0.177 | 23.964 | 0.278 | 42.657 | 0.049 | 0 | 0.002 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 353.522 | 278.471 | 0.26 | 0.082 | 0.122 | 8.741 | 6.893 | 23.964 | 0.278 | -1.533 | -4.44 | 0 | 0 |
| Kasstroom uit Financieringsactiviteiten
| 353.522 | 278.471 | 447.543 | 85.795 | 27.518 | 111.591 | 7.07 | 23.964 | 0.278 | 41.124 | -4.391 | 0 | 0.002 |
| Overige Informatie: | |||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0.376 | -2.484 | -0.592 | -0.593 | 0.406 | -0.612 | 0.753 | 1.889 | -5.744 | -4.07 | -3.027 | 0.17 | -0.314 |
| Netto Kasstroomverandering
| 91.401 | -118.446 | 130.679 | 20.254 | -42.999 | 47.268 | 3.391 | -41.556 | -13.375 | 34.076 | -22.212 | 46.234 | -0.112 |
| Kaspositie aan het Einde van de Periode
| 148.643 | 57.242 | 175.688 | 45.009 | 24.755 | 67.754 | 20.486 | 17.095 | 58.651 | 72.026 | 37.95 | 60.162 | 13.928 |